Search Results - Butrus Atrash
- Showing 1 - 1 results of 1
-
1
Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer. by Sheelagh Frame, Chiara Saladino, Craig MacKay, Butrus Atrash, Peter Sheldrake, Edward McDonald, Paul A Clarke, Paul Workman, David Blake, Daniella Zheleva
Published in PLoS ONE (2020-01-01)Get full text
Article
